Favorable indications for hepatectomy in patients with liver metastasis from gastric cancer. - Wikidata - awgldk - TriplyDB

Favorable indications for hepatectomy in patients with liver metastasis from gastric cancer.

Favorable indications for hepatectomy in patients with liver metastasis from gastric cancer.

http://www.wikidata.org/entity/Q36706401

about

Clinical modalities for management of gastric cancer hepatic metastasis Surgery for Liver Metastases From Gastric Cancer: A Meta-Analysis of Observational Studies Role of periostin and its antagonist PNDA-3 in gastric cancer metastasis Proton beam therapy for liver metastases from gastric cancer Liver resections in metastatic gastric cancer Prognostic analysis of combined curative resection of the stomach and liver lesions in 30 gastric cancer patients with synchronous liver metastases.Prognostic role of gastrectomy in patients with gastric cancer with positive peritoneal cytology.Radical gastrectomy with hepatoarterial catheter implantation for late-stage gastric cancer.Gastrectomy in comprehensive treatment of advanced gastric cancer with synchronous liver metastasis: a prospectively comparative study.Surgical treatment of liver metastases of gastric cancer: is local treatment in a systemic disease worthwhile?Capecitabine plus Cisplatin treatment for advanced gastric cancer in a patient with hepatic impairment secondary to metastases Hepatectomy for liver metastases from gastric cancer: a systematic review Radiofrequency ablation for liver metastases in patients with gastric cancer as an alternative to hepatic resection.Prognostic Value of Lymph Node Ratio in Patients Receiving Combined Surgical Resection for Gastric Cancer Liver Metastasis: Results from Two National Centers in China Combination of percutaneous radiofrequency ablation and systemic chemotherapy are effective treatment modalities for metachronous liver metastases from gastric cancer.Surgical treatment of liver metastases of gastric cancer: state of the art.Surgical resection of hepatic metastasis from gastric cancer: a review and new recommendation in the Japanese gastric cancer treatment guidelines.The benefits of liver resection for non-colorectal, non-neuroendocrine liver metastases: a systematic review.Gastric cancer and synchronous hepatic metastases: is it possible to recognize candidates to R0 resection?Metachronous liver and bone metastasis from small early gastric carcinoma without lymph node involvement: A case report.Capecitabine plus paclitaxel induction treatment in gastric cancer patients with liver metastasis: a prospective, uncontrolled, open-label Phase II clinical study.Metastatic gastric cancer (MGC) patients: Can we improve survival by metastasectomy? A systematic review and meta-analysis.Postoperative follow-up programs improve survival in curatively resected gastric and junctional cancer patients: a propensity score matched analysis.Role of hepatectomy in gastric cancer with multiple liver-limited metastases.The role of surgery in the therapeutic approach of gastric cancer liver metastases.Current management of liver metastases from gastric cancer: what is common practice? New challenge of EORTC and JCOG.Systematic review of partial hepatic resection to treat hepatic metastases in patients with gastric cancer.Japanese gastric cancer treatment guidelines 2014 (ver. 4).Liver metastases from gastric cancer represent systemic disease in comparison with those from colorectal cancer.Liver Resection for Non-colorectal Non-neuroendocrine Metastases: Where Do We Stand Today Compared to Colorectal Cancer?Efficacy and feasibility of radiofrequency ablation for liver metastases from gastric adenocarcinoma.Early detection of nonperitoneal recurrence may contribute to survival benefit after curative gastrectomy for gastric cancer.Conversion therapy for inoperable advanced gastric cancer patients by docetaxel, cisplatin, and S-1 (DCS) chemotherapy: a multi-institutional retrospective study.Systemic chemotherapy as a main strategy for liver metastases from gastric cancer.Surgical resection for hepatic metastasis from gastric cancer: a multi- institution study.Minimally invasive surgery as a treatment option for gastric cancer with liver metastasis: a comparison with open surgery.Hepatic resection for hepatic metastases from gastric adenocarcinoma.Prognostic significance of radical surgical treatment for gastric cancer patients with synchronous liver metastases.Survival benefit of gastrectomy ± metastasectomy in patients with metastatic gastric cancer receiving chemotherapy.Repeat hepatectomy for recurrent liver metastasis from gastric carcinoma.

P2860

Q26765314-4BFA7479-14F0-4ACC-B826-5FF995A90688 Q26801141-111D1D68-B5FE-43C1-97DB-5515DDBAF166 Q28088349-C5F10B64-28DE-4506-91EB-711793A1F9E0 Q33716464-A11297B3-8352-47E4-A3CC-47FB7BDAF7ED Q34394426-7C742C01-4607-4185-B8D1-CB5636A9B8B9 Q34444504-5C4A2B2B-C0E0-47AC-B431-7C783C2D2AF1 Q34623764-1DCA55AC-A9E9-4949-9121-8DB71A2C6BE1 Q35152370-9865EF37-25E1-444E-AD06-18313AC6C394 Q35816778-BD97957A-6CD8-43B2-8FF4-ECEE340092B9 Q36020122-7CF58FF4-B3A4-4193-89B4-C740F41423DE Q36153465-CD2B329F-33B5-4215-8DDA-053D9D888D6B Q36279153-EFBDF249-000A-49C3-B0B3-469DB82C7382 Q36304727-94AB8378-036A-4931-8120-56DA5DBB48DB Q36838041-8BB23FF9-9F96-4CEF-A20A-9DD55A6D7EE8 Q37480150-51536D91-37B3-40E0-BEFC-EE5B9514D3A7 Q38031998-7363A023-DD34-4B84-B2D4-3FC43AFCB8E8 Q38136068-9F8DA011-5074-4650-AD98-99C5B1009109 Q38242365-7217FCA2-77B2-4A90-A77F-76314E0F2725 Q38246199-0457C4A9-EDFE-4D01-B0DD-889D5E58B9FD Q38292698-796FD53B-2853-4053-8C5D-FAE5A3F3909B Q38391749-1B6D9BD1-3108-4B44-A055-CE6FDA9CBA2C Q38527676-290F6905-BD56-41D6-86D3-CD4BC153CAE8 Q38663129-DDDFA271-517E-4196-9C47-B543BEE27ACB Q38747280-1CFDF9CC-4FA1-4192-B3F5-AF90CC0FAEBE Q38928544-7D5E6A9B-CE6D-4771-9D96-DDE2B4E6EE31 Q38985204-4F324BAD-7869-47E9-9437-F8FC6CA17BB2 Q39012091-B4DF4FB5-AC9D-4666-B0D1-DF704B508B31 Q39656427-754E12A2-AC65-4481-8B88-4DF2CD408AC0 Q39945227-DC8912B3-0D34-485C-BCCD-D592CCDBFFBC Q39964506-406FE133-6C8B-4126-A59E-FCE6CB30C144 Q40364348-2654896D-1641-4177-B215-606C374B5074 Q40517538-0BEAD567-C4A5-4CE4-94B4-5C5D718F74FF Q40610389-68A6E61C-22FF-4E99-A113-6706E5C611FA Q41644087-AA0078D3-2EF8-42A0-BEC8-A043F08E0F21 Q42378513-CF1CCA6F-6F5B-4109-9AA6-9D79343FA848 Q42699471-96A64F7B-1608-4F94-9B9A-291FE7DD6C7F Q43101649-B1701F03-3045-4240-A256-B66939E5744D Q43619108-5C04937D-D274-402A-8B1B-AEFBA5ED630C Q43878962-BDFE78E4-463C-4CBC-B513-43EE5B4D5C1F Q44548542-67107F88-B9C8-4576-8D60-C0D8A408E2CF

P2860

Favorable indications for hepatectomy in patients with liver metastasis from gastric cancer.

http://www.wikidata.org/entity/Q36706401

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Favorable indications for hepa ...... etastasis from gastric cancer.

@ast

Favorable indications for hepa ...... etastasis from gastric cancer.

@en

type

label

Favorable indications for hepa ...... etastasis from gastric cancer.

@ast

Favorable indications for hepa ...... etastasis from gastric cancer.

@en

prefLabel

Favorable indications for hepa ...... etastasis from gastric cancer.

@ast

Favorable indications for hepa ...... etastasis from gastric cancer.

@en

P1433

Q36706401-752F9EA6-3C2A-4605-BBB4-33A7E6CF9B95

P1476

Q36706401-35163C8C-D84A-498C-8444-D1596D540ADD

P2093

Q36706401-1A71E57D-F7A3-4575-BD5E-91771AE6461C

Q36706401-1A996BD2-A4A8-4593-B528-D4D41CA0DA55

Q36706401-3A8E6841-F545-4572-A850-6FB157797FF4

Q36706401-44DFCB5A-D076-4192-9F66-1359CA55755C

Q36706401-7F632398-1CC0-42A2-BAA8-9666DE13AFA2

Q36706401-8F224815-5926-42A5-B52B-72D6224B70AD

Q36706401-B00DD025-94EF-4C73-9CDA-95EEC2DCF760

Q36706401-BF333C82-4F5F-46AF-A2E5-3EAE8E6DB9D4

Q36706401-DA657EB1-94DF-4E07-84D0-A4A4E24C42B1

P304

Q36706401-8A5376FF-AE26-4CB0-BF34-C85C0969D32A

P31

Q36706401-22D5C965-159A-40BC-B59B-834AD26D56EC

P356

Q36706401-9AF8299D-EB96-46F2-885C-30790B4C2849

P433

Q36706401-C231E8E0-1F36-4FF9-9ADB-B889DE344DA2

P478

Q36706401-FD94D651-2FEA-4D44-BB0C-2370BC6E1FC5

P577

Q36706401-209E36C4-46EA-4286-ABAF-BFFDFCCD60A2

P698

Q36706401-0DDBFD05-489D-4207-A92D-3F7BCD945F9D

P921

Q36706401-50F3A556-3786-4A68-9C92-FF55EE9537C3

P356

P1433

Journal of Surgical Oncology

P1476

Favorable indications for hepa ...... etastasis from gastric cancer.

@en

P2093

Hitoshi Katai

http://www.w3.org/2001/XMLSchema#string

Kazuaki Shimada

http://www.w3.org/2001/XMLSchema#string

Makoto Saka

http://www.w3.org/2001/XMLSchema#string

Minoru Esaki

http://www.w3.org/2001/XMLSchema#string

Mitsuru Sasako

http://www.w3.org/2001/XMLSchema#string

Takeo Fukagawa

http://www.w3.org/2001/XMLSchema#string

Takeshi Sano

http://www.w3.org/2001/XMLSchema#string

Tomoo Kosuge

http://www.w3.org/2001/XMLSchema#string

Yoshihiro Sakamoto

http://www.w3.org/2001/XMLSchema#string

P304

534-539

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JSO.20739

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

95

http://www.w3.org/2001/XMLSchema#string

P577

2007-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17219383

http://www.w3.org/2001/XMLSchema#string

P921